ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

VAXX Vaxxinity Inc

0.1411
0.0369 (35.41%)
取引時間後
最終更新日: 05:30:00
15分遅延
名称 銘柄コード 市場 種別
Vaxxinity Inc VAXX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.0369 35.41% 0.1411 05:30:00
始値 安値 高値 終値 前日終値
0.1486 0.1222 0.1488 0.1411 0.1042
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/2007:53GLOBEVaxxinity Issues Shareholder Letter
2024/4/2005:27GLOBEVaxxinity Announces Intention to Voluntarily Delist and..
2024/3/2822:23GLOBEVaxxinity to Present Clinical Data at the Annual Academy of..
2024/3/2805:41GLOBEVaxxinity Reports Fourth Quarter and Full-Year 2023..
2024/3/0800:32GLOBEVaxxinity Announces Positive Target Engagement Data from..
2024/2/1606:15EDGAR2Form 8-K - Current report
2024/2/1522:00GLOBEVaxxinity’s Cholesterol Vaccine Candidate Successfully..
2024/2/1322:00GLOBEVaxxinity to Present Clinical and Preclinical Pipeline Data..
2024/2/1307:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/1307:02EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/3022:00GLOBEVaxxinity Announces Research Collaboration on Active..
2024/1/1822:00GLOBEVaxxinity Announces Collaboration on Space Medicine Research..
2024/1/0322:00GLOBEVaxxinity to Present at the 2024 J.P. Morgan Healthcare..
2023/12/0200:30EDGAR2Form 8-K - Current report
2023/12/0107:03EDGAR2Form 144 - Report of proposed sale of securities
2023/12/0106:54EDGAR2Form 144 - Report of proposed sale of securities
2023/11/3007:13EDGAR2Form 144 - Report of proposed sale of securities
2023/11/3007:10EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2206:21EDGAR2Form 144 - Report of proposed sale of securities
2023/11/2206:20EDGAR2Form 144 - Report of proposed sale of securities
2023/11/1408:50GLOBEVaxxinity to Present at Upcoming November Medical and..
2023/11/0822:30GLOBEVaxxinity Reports Third Quarter 2023 Financial Results and..
2023/11/0821:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0405:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/10/0505:33EDGAR2Form 144 - Report of proposed sale of securities
2023/10/0505:24EDGAR2Form 144 - Report of proposed sale of securities
2023/9/2905:15EDGAR2Form 8-K - Current report
2023/9/2305:16EDGAR2Form 144 - Report of proposed sale of securities
2023/9/2305:12EDGAR2Form 144 - Report of proposed sale of securities
2023/8/2921:00GLOBEVaxxinity to Present at Upcoming Investor Conferences in..
2023/8/2113:15EDGAR2Form EFFECT - Notice of Effectiveness
2023/8/1021:00GLOBEVaxxinity Announces Publication of UB-311 Safety,..
2023/8/0921:00GLOBEVaxxinity Reports Second Quarter 2023 Financial Results and..
2023/8/0920:31EDGAR2Form S-3 - Registration statement under Securities Act of..
2023/8/0920:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/2805:30GLOBEVaxxinity Appoints Peter Powchik, M.D., to Executive Vice..
2023/7/2805:04EDGAR2Form 8-K - Current report
2023/7/1721:00GLOBEVaxxinity Demonstrates Target Engagement of Toxic..
2023/6/2221:00GLOBEVaxxinity Announces UB-312 Successfully Met Primary..
2023/5/0921:00GLOBEVaxxinity Reports First Quarter 2023 Financial Results and..

最近閲覧した銘柄

Delayed Upgrade Clock